z-logo
open-access-imgOpen Access
HbA1c –Marker for Long Term Glycemic Control
Author(s) -
Ajay Puri,
Jyoti Kohli,
V.J. Chrunjoo
Publication year - 2020
Publication title -
asian journal of medical research
Language(s) - English
Resource type - Journals
eISSN - 2347-3398
pISSN - 2277-7253
DOI - 10.47009/ajmr.2020.9.1.bc1
Subject(s) - glycation , glycemic , medicine , glycated hemoglobin , diabetes mellitus , type 2 diabetes mellitus , endocrinology , hemoglobin , pathogenesis , metabolic control analysis , type 2 diabetes
Background: Protein glycation is a spontaneous reaction that is believed to play a key role in the pathogenesis of many clinical disorders. The glycation of proteins is enhanced by elevated blood glucose concentrations. The major form of protein glycation with a clinical consideration is glycatedhaemoglobin (HbA1c). HbA1c is majorly affected by the blood glucose levels alone. Diabetes mellitus is a metabolic disorder characterized by hyperglycemia. Studies have suggested that HbA1c levels in type-2 diabetes mellitus patients mostly remains elevated, yet some such patients, with or without tight glycemic control, have HbA1c levels nearly close to or within the normal reference range.Subjects and Methods:In this study HbA1c, fasting blood glucose levels and post prandial blood glucose levels in normal subjects as well as in patients with Type-2 diabetes mellitus excluding the complicated ones were studied.Results:The present study confirms earlier studies that all these levels are tightly correlated and the corresponding p values were < 0.001 which were significant and was estimated by using student t-test.Conclusion: Thus indicating that glycated hemoglobin (HbA1c) can be used to assess the glycemic status of an individual for attaining the treatment goal of preventing long term complications of diabetes mellitus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here